Manuel Torres-Diz

457 total citations
11 papers, 218 citations indexed

About

Manuel Torres-Diz is a scholar working on Molecular Biology, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, Manuel Torres-Diz has authored 11 papers receiving a total of 218 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 7 papers in Oncology and 2 papers in Pathology and Forensic Medicine. Recurrent topics in Manuel Torres-Diz's work include RNA modifications and cancer (5 papers), Lung Cancer Research Studies (4 papers) and Chromatin Remodeling and Cancer (3 papers). Manuel Torres-Diz is often cited by papers focused on RNA modifications and cancer (5 papers), Lung Cancer Research Studies (4 papers) and Chromatin Remodeling and Cancer (3 papers). Manuel Torres-Diz collaborates with scholars based in Spain, United States and Netherlands. Manuel Torres-Diz's co-authors include Montse Sánchez‐Céspedes, Octavio A. Romero, Antonio Gómez, Eva Pros, Luis M. Montuenga, Sebastián Morán, Takashi Kohno, Carmen Sáez, Suvi Savola and Reika Iwakawa and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Blood and Cancer Research.

In The Last Decade

Manuel Torres-Diz

10 papers receiving 217 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Manuel Torres-Diz Spain 6 158 75 49 37 32 11 218
Sook Kyung South Korea 8 105 0.7× 104 1.4× 50 1.0× 18 0.5× 65 2.0× 29 229
Álvaro Andrades Spain 8 143 0.9× 31 0.4× 49 1.0× 44 1.2× 15 0.5× 16 168
Eli Grunblatt United States 5 161 1.0× 149 2.0× 46 0.9× 13 0.4× 42 1.3× 11 268
Monika Kowal Poland 9 141 0.9× 53 0.7× 53 1.1× 23 0.6× 42 1.3× 15 258
Ian Y. Luk Australia 9 134 0.8× 61 0.8× 48 1.0× 21 0.6× 29 0.9× 11 214
Nicola Alesi United States 7 104 0.7× 58 0.8× 15 0.3× 22 0.6× 74 2.3× 11 260
E. L. Woodward Sweden 8 113 0.7× 50 0.7× 33 0.7× 25 0.7× 20 0.6× 14 225
Hai Jiang China 8 232 1.5× 46 0.6× 76 1.6× 21 0.6× 39 1.2× 18 333
Sophie Shifman United States 3 69 0.4× 66 0.9× 47 1.0× 31 0.8× 84 2.6× 5 174
Vera Riehmer Germany 7 142 0.9× 33 0.4× 46 0.9× 9 0.2× 31 1.0× 11 229

Countries citing papers authored by Manuel Torres-Diz

Since Specialization
Citations

This map shows the geographic impact of Manuel Torres-Diz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Manuel Torres-Diz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Manuel Torres-Diz more than expected).

Fields of papers citing papers by Manuel Torres-Diz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Manuel Torres-Diz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Manuel Torres-Diz. The network helps show where Manuel Torres-Diz may publish in the future.

Co-authorship network of co-authors of Manuel Torres-Diz

This figure shows the co-authorship network connecting the top 25 collaborators of Manuel Torres-Diz. A scholar is included among the top collaborators of Manuel Torres-Diz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Manuel Torres-Diz. Manuel Torres-Diz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Torres-Diz, Manuel, Clara Reglero, Katharina E. Hayer, et al.. (2024). An Alternatively Spliced Gain-of-Function NT5C2 Isoform Contributes to Chemoresistance in Acute Lymphoblastic Leukemia. Cancer Research. 84(20). 3327–3336. 3 indexed citations
2.
Ang, Zhiwei, Katharina E. Hayer, Zainul S. Hasanali, et al.. (2024). P2RX5-Directed CAR-T Cells for Genotype-Guided Treatment of Lymphoid and Plasma Cell Malignancies in Patients of African Ancestry. Blood. 144(Supplement 1). 1033–1033.
3.
Alburquerque-Béjar, Juan J., Maria Saigí, Antonio Gómez, et al.. (2023). MYC activation impairs cell-intrinsic IFNγ signaling and confers resistance to anti-PD1/PD-L1 therapy in lung cancer. Cell Reports Medicine. 4(4). 101006–101006. 19 indexed citations
4.
Closa, Adrià, Antonio C. Fuentes-Fayos, Katharina E. Hayer, et al.. (2022). A convergent malignant phenotype in B-cell acute lymphoblastic leukemia involving the splicing factor SRRM1. NAR Cancer. 4(4). zcac041–zcac041. 5 indexed citations
5.
Lanauze, Claudia, Priyanka Sehgal, Katharina E. Hayer, et al.. (2021). Colorectal Cancer-Associated Smad4 R361 Hotspot Mutations Boost Wnt/β-Catenin Signaling through Enhanced Smad4–LEF1 Binding. Molecular Cancer Research. 19(5). 823–833. 9 indexed citations
6.
Torres-Diz, Manuel, Antonio Gómez, Octavio A. Romero, et al.. (2021). MAX mutant small-cell lung cancers exhibit impaired activities of MGA-dependent noncanonical polycomb repressive complex. Proceedings of the National Academy of Sciences. 118(37). 7 indexed citations
7.
Schulz, Laura, Manuel Torres-Diz, Mariela Cortés-López, et al.. (2021). Direct long-read RNA sequencing identifies a subset of questionable exitrons likely arising from reverse transcription artifacts. Genome biology. 22(1). 190–190. 17 indexed citations
8.
Mitsuishi, Yoichiro, Peter S. Choi, Diana Cai, et al.. (2019). Multi-Omics Analysis Identifies MGA as a Negative Regulator of the MYC Pathway in Lung Adenocarcinoma. Molecular Cancer Research. 18(4). 574–584. 26 indexed citations
9.
Romero, Octavio A., Sara Verdura, Manuel Torres-Diz, et al.. (2016). Sensitization of retinoids and corticoids to epigenetic drugs in MYC-activated lung cancers by antitumor reprogramming. Oncogene. 36(9). 1287–1296. 5 indexed citations
10.
Torres-Diz, Manuel, Eva Pros, Antonio Gómez, et al.. (2014). Abstract 2477: Max inactivation in small cell lung cancer disrupts the MYC-SWI/SNF programs and is synthetic lethal with BRG1. Cancer Research. 74(19_Supplement). 2477–2477. 1 indexed citations
11.
Romero, Octavio A., Manuel Torres-Diz, Eva Pros, et al.. (2013). MAX Inactivation in Small Cell Lung Cancer Disrupts MYC–SWI/SNF Programs and Is Synthetic Lethal with BRG1. Cancer Discovery. 4(3). 292–303. 126 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sook Kyung Breakdown of academic impact, for papers by Álvaro Andrades Breakdown of academic impact, for papers by Eli Grunblatt Breakdown of academic impact, for papers by Monika Kowal Breakdown of academic impact, for papers by Ian Y. Luk Breakdown of academic impact, for papers by Nicola Alesi Breakdown of academic impact, for papers by E. L. Woodward Breakdown of academic impact, for papers by Hai Jiang Breakdown of academic impact, for papers by Sophie Shifman Breakdown of academic impact, for papers by Vera Riehmer
Rankless by CCL
2026